Achieve Life Sciences, Inc. (ACHV)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Thomas B. King M.B.A. | Interim Executive Chairman | 50.13k | -- | 1955 |
| Dr. Richard A. B. Stewart | CEO & Executive Director | 892.13k | -- | 1959 |
| Dr. Cindy Jacobs M.D., Ph.D. | President, Chief Medical Officer & Director | 775.47k | -- | 1958 |
| Mr. Mark K. Oki CPA | Chief Financial Officer | 425.24k | -- | 1969 |
| Mr. Jerry Wan | VP of Finance & Principal Accounting Officer | -- | -- | 1982 |
| Dr. Anthony Clarke Ph.D. | Chief Scientific Officer | 546k | -- | 1956 |
| Ms. Jaime Xinos | Chief Commercial Officer | -- | -- | 1977 |
| Dr. Mark L. Rubinstein | Head of Medical Affairs | -- | -- | -- |
| Mr. Craig Donnelly | Executive Vice President of CMC & Regulatory CMC | -- | -- | -- |
Achieve Life Sciences, Inc.
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 25
Description
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license and supply agreement with Sopharma AD and University of Bristol Achieve Life Sciences, Inc., which is headquartered in Vancouver, Canada.
Corporate Governance
Upcoming Events
August 11, 2025 at 10:59 AM UTC - August 15, 2025 at 12:00 PM UTC
Achieve Life Sciences, Inc. Earnings Date
Recent Events
November 14, 2024 at 12:00 AM UTC
CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission
November 7, 2024 at 12:00 AM UTC
POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing